Shanghai LePure Biotech was established in 2011. It pioneered localization of single-use solutions ，cell culture solution and downstream purification for biopharmaceutical industry in China. LePure has comprehensive capabilities in R&D, manufacturing, and commercial operation. LePure is a customer-centric company with a commitment to high quality and continuous improvement. Driven by technology innovation, the company strives to be the most reliable partner of global biopharma. LePure’s mission is to empower Biopharm customers with high quality and innovative bioprocess solutions.
LePure Biotech has a management team with vision and innovative mindset. Many members brings years of experience working in the global enterprises in related fields: a global R&D team with 10% of members having a master's degree or above (6 are PhD’s) taking on nearly 100 ongoing R&D projects, a senior technical team with experts in the field of biopharmaceuti cals, a production team with more than 10 years of experience in lean manufacturing, a professional quality team with rich knowledge in advanced quality management concepts and years of devotion to life science industry, a multinational team of GMP, regulation and technical consultants and well equipped validation services team.
Over the years, LePure attracted investment of many well-known venture capitals such as Shanghai Pudong Innotek Capital Co. Ltd., CICC Capital, Hillhouse Capital, etc. Driven by technology innovation, LePure Biotech continuously solves biopharmaceutical “bottleneck” problems, explores single-use systems industry chains. It has become a trusted partner of global biopharmaceutical companies, promoted a healthy and rapid development of biopharmaceutical industry in China, and in the world, and made positive contributions to more precise and effective biopharmaceuticals manufacturing for benefits of general public.
LePure Biotech serves a wide range of biopharma customers in monoclonal antibody, vaccine, cell and gene therapy industries. LePure Biotech specializes in single-use bioprocess solutions for the entire biopharmaceuticals manufacturing process from upstream cell culture, downstream purification and final filling in bioprocessing. Its products are applicable through the stages of R&D, pilot scale and commercial production. LePure Biotech aims to build a secure biopharmaceuticals supply chain and accelerates the process of single-use technology localization.
The video meeting will now begin